Cargando…

Computational Insights into the Role of Cholesterol in Inverted Hexagonal Phase Stabilization and Endosomal Drug Release

[Image: see text] Cholesterol is a major component of many lipid-based drug delivery systems, including cationic lipid nanoparticles. Despite its critical role in the drug release stage, the underlying molecular mechanism by which cholesterol assists in endosomal escape remains unclear. An efficient...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramezanpour, Mohsen, Tieleman, D. Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220946/
https://www.ncbi.nlm.nih.gov/pubmed/35675506
http://dx.doi.org/10.1021/acs.langmuir.2c00430
_version_ 1784732500820492288
author Ramezanpour, Mohsen
Tieleman, D. Peter
author_facet Ramezanpour, Mohsen
Tieleman, D. Peter
author_sort Ramezanpour, Mohsen
collection PubMed
description [Image: see text] Cholesterol is a major component of many lipid-based drug delivery systems, including cationic lipid nanoparticles. Despite its critical role in the drug release stage, the underlying molecular mechanism by which cholesterol assists in endosomal escape remains unclear. An efficient drug release from the endosome requires endosomal disruption. This disruption is believed to involve a lamellar-to-inverted hexagonal (L(α)–H(II)) phase transition upon fusion of the lipid nanoparticle with the endosomal membrane. We used molecular dynamics simulations to study the structural properties of H(II) systems composed of an anionic lipid distearoyl phosphatidylserine (DSPS), an ionizable cationic lipid (KC2H), and cholesterol for several hydration levels and molar ratios. This system corresponds to the lipid mixtures in the hypothesized H(II) structure formed upon fusion and is of interest for the rational design of ionizable cationic lipids, including KC2, for an optimal drug release. Simulations suggest a geometry- and symmetry-driven lipid sorting and cholesterol–DSPS co-location around the water cores. Cholesterol preferentially co-locates with negatively charged saturated DSPS lipids at interstitial angles. The observed cholesterol–DSPS co-location results in an overall increase in the DSPS acyl chains’ order parameters, which we propose to assist in stabilizing the H(II) phase by stretching the DSPS acyl chains for filling the voids formed by three adjacent lipid tubules. Furthermore, a systematic increase in the cholesterol concentration increased the lattice plane spacing and the water core radius but decreased the undulations along the lipid tubule axis. We propose that cholesterol and the degree of saturation/polyunsaturation of the lipid acyl chains, and not the lipid charge, are the main contributors in facilitating the L(α)–H(II) phase transition and stabilizing/destabilizing the formed H(II) phase, whereas the positive charge of the ionizable cationic lipid promotes the LNP–endosomal membrane adhesion and assists in initiating the fusion process at the local contact area. We also propose that the effect of cholesterol on the H(II) structure and curvature is the main underlying reason for the well-documented H(II) stabilization and destabilization at low and high molar concentrations of cholesterol, respectively.
format Online
Article
Text
id pubmed-9220946
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-92209462023-06-08 Computational Insights into the Role of Cholesterol in Inverted Hexagonal Phase Stabilization and Endosomal Drug Release Ramezanpour, Mohsen Tieleman, D. Peter Langmuir [Image: see text] Cholesterol is a major component of many lipid-based drug delivery systems, including cationic lipid nanoparticles. Despite its critical role in the drug release stage, the underlying molecular mechanism by which cholesterol assists in endosomal escape remains unclear. An efficient drug release from the endosome requires endosomal disruption. This disruption is believed to involve a lamellar-to-inverted hexagonal (L(α)–H(II)) phase transition upon fusion of the lipid nanoparticle with the endosomal membrane. We used molecular dynamics simulations to study the structural properties of H(II) systems composed of an anionic lipid distearoyl phosphatidylserine (DSPS), an ionizable cationic lipid (KC2H), and cholesterol for several hydration levels and molar ratios. This system corresponds to the lipid mixtures in the hypothesized H(II) structure formed upon fusion and is of interest for the rational design of ionizable cationic lipids, including KC2, for an optimal drug release. Simulations suggest a geometry- and symmetry-driven lipid sorting and cholesterol–DSPS co-location around the water cores. Cholesterol preferentially co-locates with negatively charged saturated DSPS lipids at interstitial angles. The observed cholesterol–DSPS co-location results in an overall increase in the DSPS acyl chains’ order parameters, which we propose to assist in stabilizing the H(II) phase by stretching the DSPS acyl chains for filling the voids formed by three adjacent lipid tubules. Furthermore, a systematic increase in the cholesterol concentration increased the lattice plane spacing and the water core radius but decreased the undulations along the lipid tubule axis. We propose that cholesterol and the degree of saturation/polyunsaturation of the lipid acyl chains, and not the lipid charge, are the main contributors in facilitating the L(α)–H(II) phase transition and stabilizing/destabilizing the formed H(II) phase, whereas the positive charge of the ionizable cationic lipid promotes the LNP–endosomal membrane adhesion and assists in initiating the fusion process at the local contact area. We also propose that the effect of cholesterol on the H(II) structure and curvature is the main underlying reason for the well-documented H(II) stabilization and destabilization at low and high molar concentrations of cholesterol, respectively. American Chemical Society 2022-06-08 2022-06-21 /pmc/articles/PMC9220946/ /pubmed/35675506 http://dx.doi.org/10.1021/acs.langmuir.2c00430 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Ramezanpour, Mohsen
Tieleman, D. Peter
Computational Insights into the Role of Cholesterol in Inverted Hexagonal Phase Stabilization and Endosomal Drug Release
title Computational Insights into the Role of Cholesterol in Inverted Hexagonal Phase Stabilization and Endosomal Drug Release
title_full Computational Insights into the Role of Cholesterol in Inverted Hexagonal Phase Stabilization and Endosomal Drug Release
title_fullStr Computational Insights into the Role of Cholesterol in Inverted Hexagonal Phase Stabilization and Endosomal Drug Release
title_full_unstemmed Computational Insights into the Role of Cholesterol in Inverted Hexagonal Phase Stabilization and Endosomal Drug Release
title_short Computational Insights into the Role of Cholesterol in Inverted Hexagonal Phase Stabilization and Endosomal Drug Release
title_sort computational insights into the role of cholesterol in inverted hexagonal phase stabilization and endosomal drug release
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220946/
https://www.ncbi.nlm.nih.gov/pubmed/35675506
http://dx.doi.org/10.1021/acs.langmuir.2c00430
work_keys_str_mv AT ramezanpourmohsen computationalinsightsintotheroleofcholesterolininvertedhexagonalphasestabilizationandendosomaldrugrelease
AT tielemandpeter computationalinsightsintotheroleofcholesterolininvertedhexagonalphasestabilizationandendosomaldrugrelease